| __timestamp | Alnylam Pharmaceuticals, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 63977978 |
| Thursday, January 1, 2015 | 41097000 | 106222897 |
| Friday, January 1, 2016 | 47159000 | 49743515 |
| Sunday, January 1, 2017 | 89912000 | 66790840 |
| Monday, January 1, 2018 | 74908000 | 76442505 |
| Tuesday, January 1, 2019 | 219750000 | 71755303 |
| Wednesday, January 1, 2020 | 492853000 | 327698465 |
| Friday, January 1, 2021 | 844287000 | 179600000 |
| Saturday, January 1, 2022 | 1037418000 | 278267003 |
| Sunday, January 1, 2023 | 1828292000 | 238278313 |
| Monday, January 1, 2024 | 2248243000 |
Igniting the spark of knowledge
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and innovation. Alnylam Pharmaceuticals, Inc. and MorphoSys AG, two prominent players in the industry, have shown contrasting revenue trajectories over the past decade.
From 2014 to 2023, Alnylam Pharmaceuticals experienced a staggering increase in revenue, growing by over 3,500%, from approximately $50 million to nearly $1.83 billion. This impressive growth reflects Alnylam's successful product launches and strategic market expansions. In contrast, MorphoSys AG's revenue growth was more modest, with a peak in 2020 at around $328 million, before stabilizing at approximately $238 million in 2023.
These trends highlight the varying strategies and market conditions faced by these companies, offering valuable insights into the competitive landscape of the biotech sector.
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Alnylam Pharmaceuticals, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited?
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Catalent, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.?
Revenue Showdown: Alnylam Pharmaceuticals, Inc. vs Perrigo Company plc
Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Revenue Insights: Alnylam Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or MiMedx Group, Inc.?
Who Generates More Revenue? Pharming Group N.V. or MorphoSys AG
MorphoSys AG and Bausch Health Companies Inc.: A Comprehensive Revenue Analysis
MorphoSys AG or Merus N.V.: Who Leads in Yearly Revenue?
MorphoSys AG vs Travere Therapeutics, Inc.: Annual Revenue Growth Compared